SEC Form 4 · accession 0001127602-16-047792
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Baldini
Officer — EVP, Pres Global Operations
Period of report
Mar 28, 2016
Accepted (ET)
Mar 30, 2016 · 2:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 90,376 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $20.41 | Mar 28, 2016 | A | 10,000 | A | — | Mar 28, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to President, Global Operations, and vest in three equal installments from the date of grant (i.e., one-third per year until fully vested on March 28, 2019).